The natural history of gastro-oesophageal reflux symptoms in the community and its effects on survival: a longitudinal 10-year follow-up study

被引:20
作者
Ford, A. C. [1 ,2 ]
Forman, D. [3 ,4 ]
Bailey, A. G. [1 ]
Axon, A. T. R. [1 ]
Moayyedi, P. [5 ]
机构
[1] St James Univ Hosp, Leeds Gastroenterol Inst, Leeds LS9 7TF, W Yorkshire, England
[2] Univ Leeds, Leeds Inst Mol Med, Leeds, W Yorkshire, England
[3] Univ Leeds, Sch Med, Ctr Biostat & Epidemiol, Leeds LS2 9JT, W Yorkshire, England
[4] Int Agcy Res Canc, Canc Informat Sect, F-69372 Lyon, France
[5] McMaster Univ, Hlth Sci Ctr, Div Gastroenterol, Hamilton, ON, Canada
关键词
QUALITY-OF-LIFE; IRRITABLE-BOWEL-SYNDROME; FUNCTIONAL GASTROINTESTINAL DISORDERS; CLINICAL SPECTRUM; GENERAL-POPULATION; CONSULTATION BEHAVIOR; LEEDS DYSPEPSIA; RISK-FACTOR; PREVALENCE; DISEASE;
D O I
10.1111/apt.12169
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Gastro-oesophageal reflux symptoms (GERS) are common in the community. However, few studies have examined their long-term natural history, or impact on survival. Aim To examine these issues in individuals recruited into a community-based screening programme for Helicobacter pylori in 1994. Methods Data on mortality and cause of death at 10 years were obtained from the Office for National Statistics. Baseline demographic data, lifestyle factors, gastrointestinal symptoms and quality of life were recorded at study entry. The effect of all these factors on persistent and new-onset GERS, and 10-year mortality, were examined using univariate and multivariate analysis, with results expressed as odds ratios (ORs) or hazard ratios (HR) with 99% confidence intervals (CI). Results Of 3967 individuals providing complete GERS data at baseline and 10 years, 549 (13.8%) had GERS at baseline. Of these, 183 (33.3%) had persistent symptoms. Among 3418 individuals asymptomatic at baseline, approximately 0.8% per year developed new-onset GERS. No predictors of persistent GERS were identified. New-onset symptoms were associated with lower quality of life or presence of irritable bowel syndrome (IBS) at baseline, and higher body mass index (BMI) at 10 years. There were 8331 (99.1%) of 8407 subjects providing complete GERS data at baseline, 1289 (15.5%) of whom were symptomatic. Presence of GERS at baseline did not affect survival (HR: 0.84; 99% CI: 0.441.59). Conclusions Gastro-oesophageal reflux symptoms persisted in one-third of individuals, whilst new-onset gastro-oesophageal reflux symptoms were associated with poor quality of life, irritable bowel syndrome and higher body mass index. Gastro-oesophageal reflux symptoms did not impact adversely on survival.
引用
收藏
页码:323 / 331
页数:9
相关论文
共 37 条
[1]  
Agréus L, 2001, AM J GASTROENTEROL, V96, P2905
[2]   Mortality associated with gastroesophageal reflux disease and its non-malignant complications: a systematic review [J].
Becher, Anja ;
El-Serag, Hashem B. .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2008, 43 (06) :645-653
[3]   Prevalence, clinical spectrum and atypical symptoms of gastro-oesophageal reflux in Argentina: a nationwide population-based study [J].
Chiocca, JC ;
Olmos, JA ;
Salis, GB ;
Soifer, LO ;
Higa, R ;
Marcolongo, M .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 22 (04) :331-342
[4]   Prevalence and clinical spectrum of gastroesophageal reflux: A population-based study in Asan-si, Korea [J].
Cho, YS ;
Choi, MG ;
Jeong, JJ ;
Chung, WC ;
Lee, IS ;
Kim, SW ;
Han, SW ;
Choi, KY ;
Chung, IS .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (04) :747-753
[5]   Epidemiology of gastrooesophageal reflux disease: A systematic review [J].
Dent, J ;
El-Serag, HB ;
Wallander, MA ;
Johansson, S .
GUT, 2005, 54 (05) :710-717
[6]  
Dupuy H., 1984, ASSESSMENT QUALITY L, P170
[7]   Systematic review: the epidemiology of gastro-oesophageal reflux disease in primary care, using the UK General Practice Research Database [J].
El-Serag, H. ;
Hill, C. ;
Jones, R. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 29 (05) :470-480
[8]   Fluctuation of gastrointestinal symptoms in the community: a 10-year longitudinal follow-up study [J].
Ford, A. C. ;
Forman, D. ;
Bailey, A. G. ;
Axon, A. T. R. ;
Moayyedi, P. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 28 (08) :1013-1020
[9]   Will the history and physical examination help establish that irritable bowel syndrome is causing this patient's lower gastrointestinal tract symptoms? [J].
Ford, Alexander C. ;
Talley, Nicholas J. ;
van Zanten, Sander J. O. Veldhuyzen ;
Vakil, Nimish B. ;
Simel, David L. ;
Moayyedi, Paul .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (15) :1793-1805
[10]   Irritable bowel syndrome: A 10-yr natural history of symptoms and factors that influence consultation behavior [J].
Ford, Alexander C. ;
Forman, David ;
Bailey, Alastair G. ;
Axon, Anthony T. R. ;
Moayyedi, Paul .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (05) :1229-1239